血栓通注射液辅治心绞痛型冠心病合并2型糖尿病94例疗效观察

Clinical effect observation of Xueshuantong injection as adjuvant treatment for 52 cases of angina type of coronary heart disease combined type 2 diabetes

目的探讨血栓通注射液辅治心绞痛型冠心病合并2型糖尿病的临床疗效。方法回顾性分析2012年3月至2014年1月期间在我院住院治疗的94例心绞痛型冠心病合并2型糖尿患者,经过医院伦理委员会审批后按照随机原则分为两组,其中观察组47例患者采用西药加血栓通治疗,对照组47例患者仅采用西医治疗,对比两组患者治疗后的心绞痛缓解情况以及心电图改善情况。结果观察组患者治疗后心绞痛总有效率、心电图改善总有效率明显高于对照组患者(P<0.05)。结论血栓通注射液在用于辅助治疗心绞痛型冠心病合并2型糖尿病中,比单纯的西医治疗能更快起效,缓解患者症状,值得临床推广。

Objective：To discuss the clinical effect of Xueshuantong injection as adjuvant treatment for angina type of coronary heart disease combined type 2 diabetes. Methods：Ninety-four cases of angina type of coronary heart disease com-bined type 2 diabetes from March 2012 to January 2014 were retrospectively analyzed and divided randomly into 2 groups. 47 cases in the observation group were given western medicine combined Xueshuantong injection for treatment while 47 ca-ses of the control group were given simple western medicine for treatment. Angina remission condition and ECG improve-ment after treatment of the 2 groups were compared. Result：After treatment,total effective rate of angina and ECG im-provement of observation group were significantly higher than those of the control group（P ﹤ 0. 05）. Conclusion：Xueshuan-tong injection as adjuvant treatment for angina type of coronary heart disease combined type 2 diabetes has a faster clinical effect on relieving symptoms of patietns than simple western medicine.